20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) operates in the SHELL COMPANIES industry and is headquartered in New York, United States. Its market capitalization is roughly $650 million. In the fiscal year ended 2025-12-31, DMII reported $0M in revenue and $4M in net income.
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $0M | — |
| Operating Income (EBIT) | ($1M) | ($1M) | $0M |
| Operating Margin % | — | — | — |
| Net Income | $13M | $4M | $0M |
| Net Margin % | — | — | — |
| EBITDA | — | ($1M) | $0M |
| Earnings Per Share (EPS) | $0.23 | $0.32 | $-0.00 |
| Shares Outstanding (M) | 50M | 13M | 64M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | $0M | $0M | ($1M) | $0M | $0M | $0M | $0M |
| Operating Margin % | — | — | — | — | — | — | — |
| Net Income | $4M | $4M | $4M | $0M | $0M | $0M | $0M |
| Net Margin % | — | — | — | — | — | — | — |
| EBITDA | $0M | $0M | — | $0M | $0M | $0M | $0M |
| Earnings Per Share (EPS) | $0.09 | $0.09 | $0.07 | — | $-0.00 | $-0.00 | $-0.00 |
| Shares Outstanding (M) | 50M | 50M | 64M | — | 33M | 64M | 64M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Cash from Operations (CFO) | ($1M) | ($1M) | $0M |
| Capital Expenditures (CapEx) | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($1M) | ($1M) | $0M |
| FCF Margin % | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $0M | $0M | $0M | ($1M) | $0M | $0M |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | $0M | $0M | $0M | ($1M) | $0M | $0M |
| FCF Margin % | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Assets | $514M | $505M | $0M |
| Cash & Cash Equivalents | $0M | $0M | $0M |
| Total Liabilities | $18M | $18M | $0M |
| Total Debt (Short + Long-Term) | $0M | $0M | $0M |
| Total Shareholders' Equity | $496M | $487M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DMII viewer.
About TickerBase · Data methodology & sources · Privacy · Terms